SCHEMBL5334361

SCHEMBL5334361 is a drug which acts as an agonist at the 5-HT 2 family of serotonin receptors, and was developed for the treatment of glaucoma.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

SCHEMBL5334361 is a drug which acts as an agonist at the 5-HT 2 family of serotonin receptors, and was developed for the treatment of glaucoma. It is a benzazepine derivative structurally related to the anorectic drug lorcaserin. It is selective for 5-HT 2A , with an EC 50 of 0.4nM at 5-HT 2A vs 3.9nM at 5-HT 2C and a much lower affinity of 417nM at 5-HT 2B .

Text derived from https://en.wikipedia.org/w/index.php?oldid=1324498496 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.